3rd Annual Biosimilars Summit 2017

Topics

• The latest achievements of biosimilars in therapeutic areas
• The global regulatory landscape for biosimilars’ approval
• Extrapolation and Interchangeability
• Bioanalytics for biosimilars
• Pharmacovigilance issues
• Immunogenicity
• Drug safety factors
• Developments in the biosimilar guideline framework
• Successful implementation of biosimilars in the market
• Legal considerations for biosimilars

Who should Attend

Attendees involved or interested in:

• Biopharmaceuticals
• Biologics/Biotechnology/ Biogenerics
• Intellectual property
• Legal Affairs
• Clinical Immunology
• Pricing and Reimbursement
• R&D
• Regulatory Compliance
• New Product Development
• Preclinical and Clinical Development
• Pharmacovigilance
• Quality Affairs/ Quality Control